The mutant JAK2 V617F allele burden in children with essential thrombocythemia: Correspondence

British Journal of Haematology

Volumn 145, Issue 3, 2009, Pages 430-432

  Teofili, Luciana ^a   Cenci, Tonia ^a   Martini, Maurizio ^a   Capodimonti, Sara ^a   Torti, Lorenza ^a   Giona, Fiorina ^b   Amendola, Angela ^b   Randi, Maria Luigia ^c   Putti, Maria Caterina ^c   Scapin, Margherita ^c   Leone, Giuseppe ^a   Larocca, Luigi Maria ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Essential thrombocythemia; JAK2 allele burden; Polycythemia vera

Indexed keywords

ANAGRELIDE; HYDROXYUREA; INTERFERON; JANUS KINASE 2;

ADOLESCENT; ADULT; AGED; ARTICLE; BUDD CHIARI SYNDROME; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; JAK2 V617F GENE; LABORATORY TEST; MALE; ONSET AGE; POLYCYTHEMIA VERA; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTHEMIA; ALLELE; CASE CONTROL STUDY; GENETICS; LETTER; MIDDLE AGED; MUTATION;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES; THROMBOCYTHEMIA, ESSENTIAL;

EID: 64149112160     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07591.x     Document Type: Article

References (10)

1. Campbell, P.J., Scott, L.M., Buck, G., Wheatley, K., East, C.L., Marsden, J.T., Duffy, A., Boyd, E.M., Bench, A.J., Scott, M.A., Vassiliou, G.S., Milligan, D.W., Smith, S.R., Erber, W.N., Bareford, D., Wilkins, B.S., Reilly, J.T., Harrison, C.N., Green, A.R. United Kingdom Myeloproliferative Disorders Study Group; Medical Research Council Adult Leukaemia Working Party; Australasian Leukaemia and Lymphoma Group. (2005) Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet, 366, 1945 1953.
2. Cario, H., Schwarz, K., Herter, J.M., Komrska, V., McMullin, M.F., Minkov, M., Niemeyer, C., Pospisilova, D., Reinhard, H., Debatin, K.M. Pahl, H.L. (2008) Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera. British Journal of Haematology, 142, 622 626.
3. Carobbio, A., Antonioli, E., Guglielmelli, P., Vannucchi, A.M., Delaini, F., Guerini, V., Finazzi, G., Rambaldi, A. Barbui, T. (2008) Leukocytosis and risk stratification assessment in essential thrombocythemia. Journal of Clinical Oncology, 26, 2732 2736.
4. Randi, M.L., Putti, M.C., Scapin, M., Pacquola, E., Tucci, F., Micalizzi, C., Zanesco, L. Fabris, F. (2006) Pediatric patients with essential thrombocythemia are mostly polyclonal and V617FJAK2 negative. Blood, 108, 3600 3602.
5. Ricksten, A., Palmqvist, L., Johansson, P. Andreasson, B. (2008) Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia. Haematologica, 93, 1260 1261.
6. Scott, L.M., Scott, M.A., Campbell, P.J. Green, A.R. (2006) Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood, 108, 2435 2437.
7. Teofili, L., Giona, F., Martini, M., Cenci, T., Guidi, F., Torti, L., Palumbo, G., Amendola, A., Foà, R. Larocca, L.M. (2007) Markers of Myeloproliferative Diseases in Childhood Polycythemia Vera and Essential Thrombocythemia. Journal of Clinical Oncology, 25, 1048 1052.
8. Theocharides, A., Passweg, J.R., Medinger, M., Looser, R., Li, S., Hao-Shen, H., Buser, A.S., Gratwohl, A., Tichelli, A. Skoda, R.C. (2008) The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders. Haematologica, 93, 1890 1893.
9. Vannucchi, A.M., Antonioli, E., Guglielmelli, P., Rambaldi, A., Barosi, G., Marchioli, R., Marfisi, R.M., Finazzi, G., Guerini, V., Fabris, F., Randi, M.L., De Stefano, V., Caberlon, S., Tafuri, A., Ruggeri, M., Specchia, G., Liso, V., Rossi, E., Pogliani, E., Gugliotta, L., Bosi, A. Barbui, T. (2007a) Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood, 110, 840 846.
10. Vannucchi, A.M., Antonioli, E., Guglielmelli, P., Longo, G., Pancrazzi, A., Ponziani, V., Bogani, C., Ferrini, P.R., Rambaldi, A., Guerini, V., Bosi, A. Barbui, T. M.P.D. Research Consortium (2007b) Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden. Leukemia, 21, 1952 1959.